SAM
WST icon

Solaris Asset Management’s West Pharmaceutical WST Stock Holding History

Solaris Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-162
Closed -$12K – 434
2016
Q3 		$12K Buy
+162
New +$12.9K 0.01% 296

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Solaris Asset Management's WST Position: Q4 2016 in Review

Solaris Asset Management sold out of West Pharmaceutical (WST) in Q4 2016, closing a stake of 162 shares — an estimated $12K sold.

Solaris Asset Management first reported a position in WST in Q3 2016 and held it in 1 quarter. The position peaked at $12K in Q3 2016. 288 funds tracked by Wall St. Rank hold WST as of Q4 2016.

  • Solaris Asset Management reported no remaining West Pharmaceutical position as of Q4 2016 after selling out during the quarter.
  • Solaris Asset Management sold 162 West Pharmaceutical shares in Q4 2016, an estimated $12K.
  • Solaris Asset Management first reported a position in West Pharmaceutical in Q3 2016 and held it in 1 quarter.
  • Solaris Asset Management's West Pharmaceutical position peaked at $12K in Q3 2016.
  • 288 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2016.

Based on Solaris Asset Management's 13F filing for Q4 2016, filed 25 Jan 2017.